14 February 2025
EssilorLuxottica has confirmed the acquisition of Canadian med-tech start-up Cellview.
Cellview specialises in diagnostics through the use of retinal imaging.
EssilorLuxottica said that the acquisition furthers its commitment to “elevating industry standards and enhancing the quality of vision care.” It also builds on the company’s aim to broaden its ophthalmic instruments and solutions portfolio, as it seeks to enter the med-tech space.
Currently distributed in North America, Cellview’s solutions seek to support eye care practitioners in diagnosing retinal pathologies through the use of its ultra-widefield retinal camera.
Cellview’s products are FDA and CE approved, and are designed for use in optometry practices on the High Street as well as in ophthalmology clinics.
Distribution will initially begin across Europe, EssilorLuxottica confirmed.
Commenting on the acquisition, Francesco Milleri, chairman and CEO, and Paul du Saillant, deputy CEO at EssilorLuxottica, said: “We are happy to welcome Cellview’s team to EssilorLuxottica and to work together to accelerate our strategy in vision health.
“By integrating another pioneering company with strong expertise in R&D and world-class imaging solutions, we will provide a comprehensive portfolio of innovative technologies to the ophthalmic care community to better address the growing need of vision health and the early diagnosis of retinal pathologies.”
Pictured is EssilorLuxottica’s new nuance Audio glasses
Comments (0)
You must be logged in to join the discussion. Log in